Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
2024 Election
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Trending on Bing
Dismisses social media suit
Force remains hospitalized
CA doctor won't face trial
Ghostwriter contempt vote?
Win Commissioner's Cup
500+ charged with crimes
Oregon wildfire evacuations
Woman missing in Bahamas
LMPD chief resigns
Can no longer lock people in
Wants Cannon impeached
Robot from human skin cells
$10M illegal fireworks seized
Oil prices rise
Testifies on child welfare
DHS: Border arrests drop
Defends progressive values
Euthanized after encounter
Study: 1.8B at risk of illness
Wyo. highway to reopen
2 Montana inmates charged
Hells Angels chapter arrest
Assange lands in Australia
To back Bannon's appeal
Man sentenced to probation
Vitamins & death risk: Study
Rutte named NATO chief
Crews, studios reach deal
NK missile explodes midair
Gets 19 years in prison
Espionage trial begins
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Merck, pneumococcal vaccine
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
Merck's shot protects against 21 strains of that bacteria to prevent a severe form of pneumococcal disease and a lung infection called pneumonia.
FDA Approves Merck’s (MRK) New Vaccine, Capvaxive
The Food and Drug Administration (FDA) has approved pharmaceutical company Merck’s (NYSE:MRK) new vaccine, Capvaxive. This pneumococcal conjugate
FDA approves Capvaxive pneumococcal 21-valent conjugate vaccine
The U.S. Food and Drug Administration has approved Merck's Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults.
WebMD
8d
Big News for Older Adults: Pneumococcal Vaccine Approved
June 18, 2024 – There’s a new tool to fight invasive pneumococcal disease and pneumococcal pneumonia in adults, as the
FDA
...
SchaeffersResearch.com
8d
Merck Stock Edges Higher on FDA Vaccine Approval
Merck
's pneumococcal
vaccine
could become available later this summer The U.S. Food and Drug Administration (
FDA
) ...
BioSpace
9d
FDA Action Alert: Merck, BMS, Sarepta and More
The FDA has a packed calendar this week, with six decisions on the docket, including ones for Merck’s Keytruda, BMS's Krazati ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback